EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |